Litcius/Paper detail

Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients

Pooja Advani, Saranya Chumsri, Tanmayi Pai, Zhuo Li, Akash Sharma, Ephraim E. Parent

2021Annals of Nuclear Medicine18 citationsDOIOpen Access PDF

Abstract

BACKGROUND: mRNA COVID-19 vaccines are known to provide an immune response seen on FDG PET studies. However, the time course of this metabolic response is unknown. We here present a temporal metabolic response to mRNA COVID-19 vaccination in oncology patients undergoing standard of care FDG PET. METHODS: 262 oncology patients undergoing standard of care FDG PET were included in the analysis. 231 patients had at least one dose of mRNA COVID-19 vaccine while 31 patients had not been vaccinated. The SUVmax of the lymph nodes ipsilateral to the vaccination was compared to the contralateral to obtain an absolute change in SUVmax (ΔSUVmax). RESULTS: ΔSUVmax was more significant at shorter times between FDG PET imaging and COVID-19 mRNA vaccination, with a median ΔSUVmax of 2.6 (0-7 days), 0.8 (8-14 days), and 0.3 (> 14 days), respectively. CONCLUSION: Consideration should be given to performing FDG PET at least 2 weeks after the COVID-19 vaccine.

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VaccinationInternal medicineMEDLINEPandemicOncologyFamily medicineVirologyOutbreakInfectious disease (medical specialty)DiseaseLawPolitical scienceLymphadenopathy Diagnosis and AnalysisCOVID-19 and healthcare impactsCOVID-19 Clinical Research Studies
Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients | Litcius